Earlier this week
SAN DIEGO, Jul 01, 2008 (BUSINESS WIRE) ----Illumina, Inc. (NASDAQ:ILMN) today announced that researchers participating in a new initiative funded by the Wellcome Trust selected Illumina's Infinium HD BeadChips to analyze 90,000 DNA samples. This...
NEW YORK (AP) - Shares of genetic analysis instrument maker Illumina Inc. reached an all-time high Wednesday as analysts reaffirmed a positive sales outlook for the company. Get stories by e-mail on this topic. Shares reached $91.41 during the...
See All
2008-06-19 13:55:24 - highest-quality data available for genetic analysis applications. Mitsubishi Chemical Safety Institute offers its customers whole-genome and targeted-genotyping services using Illumina's Infinium(R) and...
Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Fredrick Clerie as Vice President of Quality Assurance and Regulatory Affairs reporting to Joel McComb, Senior Vice President and General Manager of Illumina's Life Sciences Business...
See All